Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.37
-0.38-4.9%
Ult. Agg.: Nov 6, 4:00 PM
Market sentiment signals for Akari Therapeutics (AKTX): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
3 analysts
Options Flow (P/C)
—
Avg Consensus PT
$32
+304.1%
Highest Price Target
$40
+400.0%
Lowest Price Target
$27
+237.5%
Short Interest
1.4%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Maxim Group | Jason McCarthy— | +275.0% | $30 | Upgrade | Hold→Buy |
| Apr 8, 2026 | Maxim Group | Jason McCarthy— | — | — | Downgrade | Buy→Hold |
